---
$id: https://graph.org.ai/products/commodity/51152019
$type: Product
source: UNSPSC
code: "51152019"
title: "Butamisole hydrochloride"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Butamisole hydrochloride

**UNSPSC Code**: 51152019
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antihelminthic agent with the molecular formula C15H19N3OS.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QGM18599H5, chemically known as propanamide, 2-methyl-n-(3-(2,3,5,6-tetrahydroimidazo(2,1-b)thizol-6-yl)phenyl)-, monohydrochloride, (-)- but generally known as butamisole hydrochloride, which bears US NIH Compound Identifier 166571. Most nations schedule butamisole hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, BUTAMISOLE HYDROCHLORIDE remains the US FDA Preferred Term for this commodity. Butamisole hydrochloride bears US NLM identifiers UMLS ID C0700565 and NCI Concept Code C79919. SMILES: CC(C)C(=O)NC1=CC=CC(=C1)C2CN3CCSC3=N2.CL.

